This review examined whether switching to a different antipsychotic medicine, as opposed to continuing treatment with the same one, improved people's response rates, alleviated overall and specific ...

Cobenfy was approved by the Food and Drug Administration in fall 2024 and represents the first novel approach in decades to ...

In the months after 24-year-old D.J. was diagnosed with schizophrenia, he searched online for answers to questions that felt urgent and existential.

Members of a national coalition are urging HHS and CMS to revisit what they’ve deemed a flawed measure in CMS’ Five-Star ...

Agitated patients are often prescribed antipsychotic medications and sedatives off-label, but this can pose a risk to the ...

New guidelines have been developed for the treatment of schizophrenia through a collaborative effort of international experts ...

At least some of schizophrenia’s symptoms are thought to be related to excessive dopamine activity. All prior antipsychotics have, in large part, relied on blocking this chemical messenger’s receptors ...

The rise of psychiatric meds in children raises questions about the long-term impact, skill development, and societal standards. Are we treating illness or enforcing conformity?

An 11-year-old girl who was mistaken for an adult, handcuffed and admitted to a mental health facility was given at least two ...

Society often places unrealistic expectations on mothers to be perfect caregivers This stigma can prevent women from seeking ...

I know first-hand why people go off antipsychotics, and why it is hard to stay on them. I went off of them twice on my own and paid dearly for it. I know many others who go through similar issues ...

Director of Mental Health has launched an independent investigation after an 11-year-old child was restrained at a mental ...